← FDA Drug Approvals (Drugs@FDA)
ATZUMI
NDA · New Drug Application · Sponsor: SATSUMA PHARMS · Approved 2025-04-30
Drug application
- FDA Application #
NDA217901- Application type
- New Drug Application
- Brand name
- ATZUMI
- Generic name
- DIHYDROERGOTAMINE MESYLATE
- Active ingredients
- DIHYDROERGOTAMINE MESYLATE
- Dosage form
- POWDER
- Route
- NASAL
- Marketing status
- Prescription
- Sponsor
- SATSUMA PHARMS
- Manufacturer
- Satsuma Pharmaceuticals, Inc.
- First approval
- 2025-04-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown